Incorporating Patient-Reported Outcomes Into Hepatitis C Virus Treatment Studies-Reference-Cited by-同舟云学术

Incorporating Patient-Reported Outcomes Into Hepatitis C Virus Treatment Studies

Published:2014-08 Issue:8 Volume:12 Page:1360-1362
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Evon Donna M.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference14 articles.

1. Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. 2009. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf.

2. The use of patient-reported outcomes (PRO) within comparative effectiveness research: implications for clinical practice and health care policy;Ahmed;Med Care,2012

3. Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial;Land;JAMA,2006

4. Effects of sofosbuvir-based treatment, with and without interferon, on outcome and productivity of patients with chronic hepatitis C;Younossi;Clin Gastroenterol Hepatol,2014

5. Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options;Jacobson;N Engl J Med,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient-reported outcomes in individuals with hepatitis C virus infection treated with elbasvir/grazoprevir;Patient Preference and Adherence;2018-12

2. Impact of Chronic Hepatitis B Infection on Patient-Reported Outcomes;Current Hepatology Reports;2018-10-15

3. Novel patient-reported outcomes (PROs) used in a pilot and feasibility study of a Cognitive Behavioral Coping Skills (CBCS) group intervention for patients with chronic hepatitis C;Pilot and Feasibility Studies;2018-06-27

4. Patient-reported outcomes with direct-acting antivirals for the treatment of chronic hepatitis C: current knowledge and outstanding issues;Expert Review of Gastroenterology & Hepatology;2017-01-31